• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

人群结直肠癌筛查意味着使用粪便免疫化学试验检测血红蛋白（FIT）进行 FIT：结直肠癌筛查的过去、现在和未来。

Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).

机构信息

Division of Gastroenterology, University of California San Francisco School of Medicine, San Francisco, CA, USA. ; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

Centre for Research into Cancer Prevention and Screening, University of Dundee School of Medicine, Dundee, Scotland.

出版信息

Gut Liver. 2014 Mar;8(2):117-30. doi: 10.5009/gnl.2014.8.2.117. Epub 2014 Mar 11.

DOI:10.5009/gnl.2014.8.2.117
PMID:24672652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3964261/
Abstract

Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.

摘要

粪便免疫化学检测血红蛋白（FIT）正在改变结直肠癌（CRC）的筛查方式。尽管这些检测在全球范围内都在进行，但为什么这项检测与之前的检测不同？有哪些证据支持其采用？如何最好地利用这些证据？本综述旨在回答这些问题，并深入了解 FIT 的理论和实践，以加速国际上采用 FIT 进行 CRC 筛查的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/471ace09f158/gnl-8-117-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/d1150cf3a31e/gnl-8-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/623d9d0f6249/gnl-8-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/6f74c85112b0/gnl-8-117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/471ace09f158/gnl-8-117-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/d1150cf3a31e/gnl-8-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/623d9d0f6249/gnl-8-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/6f74c85112b0/gnl-8-117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763f/3964261/471ace09f158/gnl-8-117-g004.jpg

相似文献

1
Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).人群结直肠癌筛查意味着使用粪便免疫化学试验检测血红蛋白（FIT）进行 FIT：结直肠癌筛查的过去、现在和未来。
Gut Liver. 2014 Mar;8(2):117-30. doi: 10.5009/gnl.2014.8.2.117. Epub 2014 Mar 11.
2
Evaluation of fecal immunochemical tests for colorectal cancer screening.用于结直肠癌筛查的粪便免疫化学检测评估
J Prim Care Community Health. 2013 Oct;4(4):245-50. doi: 10.1177/2150131913487561. Epub 2013 May 12.
3
Fecal Immunochemical Test: The World's Colorectal Cancer Screening Test.粪便免疫化学检测：世界领先的结直肠癌筛查检测。
Gastrointest Endosc Clin N Am. 2020 Jul;30(3):511-526. doi: 10.1016/j.giec.2020.02.011. Epub 2020 Apr 15.
4
FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test.为未来做好准备：基于风险的粪便免疫化学检测用于结直肠癌筛查的案例
Colorectal Dis. 2016 Jul;18(7):650-3. doi: 10.1111/codi.13365.
5
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.结直肠癌美国多学会专家组关于粪便免疫化学检测用于结直肠肿瘤筛查的共识声明。
Gastroenterology. 2017 Apr;152(5):1217-1237.e3. doi: 10.1053/j.gastro.2016.08.053. Epub 2016 Oct 19.
6
Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.系统评价与荟萃分析：粪便免疫化学检测血红蛋白（FIT）在有症状人群和筛查人群中检测结直肠癌的诊断准确性
Acta Gastroenterol Belg. 2019 Apr-Jun;82(2):291-299.
7
A quantitative immunochemical fecal occult blood test for colorectal neoplasia.一种用于结直肠肿瘤的定量免疫化学粪便潜血试验。
Ann Intern Med. 2007 Feb 20;146(4):244-55. doi: 10.7326/0003-4819-146-4-200702200-00003.
8
A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin.提议标准化血红蛋白粪便免疫化学检测的报告单位。
J Natl Cancer Inst. 2012 Jun 6;104(11):810-4. doi: 10.1093/jnci/djs190. Epub 2012 Apr 2.
9
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.粪便免疫化学检测筛查结直肠肿瘤的建议：美国结直肠癌多学会特别工作组的共识声明
Am J Gastroenterol. 2017 Jan;112(1):37-53. doi: 10.1038/ajg.2016.492. Epub 2016 Oct 18.
10
Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.无症状人群中的结直肠癌检测：血红蛋白粪便免疫化学检测与粪便M2型丙酮酸激酶检测的比较
Biochem Med (Zagreb). 2016;26(1):114-20. doi: 10.11613/BM.2016.012.

引用本文的文献

1
Diagnostic Accuracy of the Faecal Immunochemical Test in Triage of Symptomatic Patients Referred for Colonoscopy: A Prospective Single-Centre Study.粪便免疫化学检测在有症状患者结肠镜检查分流中的诊断准确性：一项前瞻性单中心研究
Can J Gastroenterol Hepatol. 2025 Aug 22;2025:2883395. doi: 10.1155/cjgh/2883395. eCollection 2025.
2
Bioinformatic screen with clinical validation for the identification of novel stool based mRNA biomarkers for the detection of colorectal lesions including advanced adenoma.通过临床验证的生物信息学筛选，以鉴定用于检测包括晚期腺瘤在内的结直肠病变的新型粪便mRNA生物标志物。
Sci Rep. 2025 Aug 11;15(1):29397. doi: 10.1038/s41598-025-13074-4.
3

本文引用的文献

1
Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity.在结肠镜检查能力受限的国家项目中，使用粪便免疫化学试验检测血红蛋白作为一线检测方法的临床效果。
United European Gastroenterol J. 2013 Jun;1(3):198-205. doi: 10.1177/2050640613489281.
2
Long-term mortality after screening for colorectal cancer.结直肠癌筛查后的长期死亡率。
N Engl J Med. 2013 Sep 19;369(12):1106-14. doi: 10.1056/NEJMoa1300720.
3
The impact of immunochemical faecal occult blood testing on colorectal cancer incidence.
Interventions to increase uptake in a fecal-immunochemical test population-based colorectal cancer screening program: A quasi-experimental study of first-time invitees.
在基于粪便免疫化学检测的人群结直肠癌筛查项目中提高参与率的干预措施：一项针对首次受邀者的准实验研究
Cancer. 2025 Apr 1;131(7):e35760. doi: 10.1002/cncr.35760.
4
Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test.基于粪便的结直肠癌筛查试验呈阳性后结肠镜检查结果为阴性的患者中的间期进展性腺瘤和肿瘤形成
Dig Dis Sci. 2025 Jan;70(1):350-359. doi: 10.1007/s10620-024-08748-4. Epub 2024 Nov 24.
5
A novel index combining fecal immunochemical test, DNA test, and age improves detection of advanced colorectal adenoma.一种新型联合粪便免疫化学检测、DNA 检测和年龄的指数可提高结直肠高级腺瘤的检出率。
Cancer Sci. 2024 Nov;115(11):3682-3694. doi: 10.1111/cas.16322. Epub 2024 Aug 24.
6
Application of fecal immunochemical test in colorectal cancer screening: A community-based, cross-sectional study in average-risk individuals in Hainan.粪便免疫化学检测在结直肠癌筛查中的应用：一项基于海南普通风险人群的社区横断面研究。
World J Gastrointest Oncol. 2024 Aug 15;16(8):3445-3456. doi: 10.4251/wjgo.v16.i8.3445.
7
Personalized prediction of survival rate with combination of penalized Cox models in patients with colorectal cancer.基于惩罚 Cox 模型组合的结直肠癌患者生存率个体化预测。
Medicine (Baltimore). 2024 Jun 14;103(24):e38584. doi: 10.1097/MD.0000000000038584.
8
Improving Fecal Immunochemical Test Collection for Colorectal Cancer Screening During the COVID-19 Pandemic.在新冠疫情期间改善用于结直肠癌筛查的粪便免疫化学检测样本采集
Fed Pract. 2024 May;41(Suppl 2):S29-S37. doi: 10.12788/fp.0455. Epub 2024 May 15.
9
Impact of Various Risk Factors on the Positive Fecal Immunochemical Test for Colorectal Cancer in the Iranian Population.伊朗人群中各种风险因素对结直肠癌粪便免疫化学检测阳性结果的影响。
Middle East J Dig Dis. 2023 Oct;15(4):249-256. doi: 10.34172/mejdd.2023.354. Epub 2023 Oct 30.
10
Exploring the gut DNA virome in fecal immunochemical test stool samples reveals associations with lifestyle in a large population-based study.在基于大样本的研究中，通过探索粪便免疫化学检测粪便样本中的肠道 DNA 病毒组，揭示了与生活方式的关联。
Nat Commun. 2024 Feb 29;15(1):1791. doi: 10.1038/s41467-024-46033-0.
免疫化学粪便潜血检测对结直肠癌发病率的影响。
Dig Liver Dis. 2014 Jan;46(1):82-6. doi: 10.1016/j.dld.2013.07.017. Epub 2013 Sep 4.
4
Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme.粪便免疫化学检测的使用缩小了当前肠癌筛查计划在性别、年龄和贫困方面的参与差距。
J Med Screen. 2013 Jun;20(2):80-5. doi: 10.1177/0969141313497197. Epub 2013 Jul 18.
5
Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.将风险因素与粪便免疫化学试验结果相结合，以选择接受结肠镜筛查的 CRC 筛查对象。
Gut. 2014 Mar;63(3):466-71. doi: 10.1136/gutjnl-2013-305013. Epub 2013 Aug 20.
6
JAMA Patient Page. Options for colorectal cancer screening.《美国医学会杂志》患者专页。结直肠癌筛查的选择。
JAMA. 2013 Aug 14;310(6):658. doi: 10.1001/jama.2013.57593.
7
Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT).利用血红蛋白定量粪便免疫化学检测（FIT）使结直肠癌筛查更符合目的
Clin Chem Lab Med. 2013 Nov;51(11):2065-7. doi: 10.1515/cclm-2013-0408.
8
Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer.九种粪便免疫化学检测用于结直肠癌检测的比较评估。
Acta Oncol. 2013 Nov;52(8):1667-75. doi: 10.3109/0284186X.2013.789141. Epub 2013 Apr 25.
9
Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.在综合医疗体系中，FLU-FIT 项目的效果和覆盖范围：一项多地点随机试验。
Am J Public Health. 2013 Jun;103(6):1128-33. doi: 10.2105/AJPH.2012.300998. Epub 2013 Apr 18.
10
Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening.血红蛋白定量可改善用于无创筛查的粪便免疫化学检测。
Clin Gastroenterol Hepatol. 2013 Jul;11(7):839-40. doi: 10.1016/j.cgh.2013.02.031. Epub 2013 Apr 13.